GIST patients with PDGFRA mutations showed mild sensitivity to imatinib (66%), with the exception of those with the exon 18 point mutation D842V, who were totally resistant to imatinib [12]. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.